Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-04-06 Sale |
2022-04-08 4:21 pm |
Keros Therapeutics Inc. | KROS | Rovaldi Christopher Chief Operating Officer |
1,728 | $65 | $112,320 | 8,002 (Direct) |
View |
| 2022-04-01 Sale |
2022-04-05 4:31 pm |
Keros Therapeutics Inc. | KROS | Rovaldi Christopher Chief Operating Officer |
864 | $57.49 | $49,675 | 9,730 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-18 Option Award |
2025-02-19 4:15 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | Rovaldi Christopher Chief Operating Officer |
60,000 | $0 | 60,000 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 8:38 pm |
N/A 2034-02-12 |
Keros Therapeutics Inc. | KROS | Rovaldi Christopher CHIEF OPERATING OFFICER |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-17 4:19 pm |
N/A 2033-02-15 |
Keros Therapeutics Inc. | KROS | Rovaldi Christopher Chief Operating Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-04-06 Exercise |
2022-04-08 4:21 pm |
N/A 2030-04-07 |
Keros Therapeutics Inc. | KROS | Rovaldi Christopher Chief Operating Officer |
1,728 | $0 | 8,002 (Direct) |
View |
| 2022-04-06 Exercise |
2022-04-08 4:21 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | Rovaldi Christopher Chief Operating Officer |
1,728 | $16 | 8,002 (Direct) |
View |
| 2022-04-01 Exercise |
2022-04-05 4:31 pm |
N/A 2030-04-07 |
Keros Therapeutics Inc. | KROS | Rovaldi Christopher Chief Operating Officer |
864 | $0 | 9,730 (Direct) |
View |
| 2022-04-01 Exercise |
2022-04-05 4:31 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | Rovaldi Christopher Chief Operating Officer |
864 | $16 | 9,730 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:45 pm |
N/A 2032-01-31 |
Keros Therapeutics Inc. | KROS | Rovaldi Christopher Chief Operating Officer |
100,000 | $0 | 100,000 (Direct) |
View |
Ownership |
2022-02-03 4:37 pm |
N/A 2029-09-18 |
Keros Therapeutics Inc. | KROS | Rovaldi Christopher Chief Operating Officer |
0 | $0 | 32,898 (Direct) |
View |